Notable
HY07121 Powder for Solution for Infusion · Advanced Solid Tumors
Primary completion pushed from May 2026 to May 26, 2027
Also in this update: Study completion pushed from Oct 2026 to Oct 26, 2027
Sichuan Huiyu Pharmaceutical Co., LtdPhase 1/2 NCT06639256 Registry history of NCT06639256 on ClinicalTrials.gov (opens the registry)